RELAXORelaxo Footwears Limited
Consumer Durable · Footwear & Accessories · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Relaxo Footwears Limited engages in the manufacture and sale of footwear for men, women, and kids in India and internationally. It offers casual, running, athleisure, walking, sneakers, formal, sports, school, and training and gym shoes; and slippers, sandals, flip flops, slides, chappals, and clogs, as well as footwear accessories. The company provides its products under the Relaxo, Bahamas, Flite, Sparx, BOSTON, Mary Jane, Schoolmate, and KidsFun brands. It sells its products through exclusive brand outlets and e-commerce portals. Relaxo Footwears Limited was founded in 1976 and is based in New Delhi, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on RELAXO — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why avoid
- • Overall evidence is weak (AlgoScore 35/100)
- • Revenue growth: 7.7% YoY
- • ROE: 8.1%
- • RSI: 23
- • MACD: bearish
Bull case
- • Debt/Equity: 0.11
- • Promoter holding: 71.3%
- • Golden cross setup: SMA50 above SMA200
- • Trend strength (ADX): 30
Bear case
- • Revenue growth: 7.7% YoY
- • ROE: 8.1%
- • RSI: 23
- • MACD: bearish
Key risks
- • Weak fundamentals — technical strength may not sustain
- • Momentum is fading versus the broader market
- • Revenue growth: 7.7% YoY
- • ROE: 8.1%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹12.90). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.